Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Check out PYN. Maybe we can make back our money there.
Ron.
Sad.
I hope it's a share swap rather than another pp.
Ron.
Probably depends on the whims of T.O.
Ron.
Good luck to us!!
Ron.
I'm still around and still have a few shares.
Ron.
That's talent!!!
Ron.
I bought some yesterday.
Ron.
Anyone know what happened to APCSF ? I can't get a quote on it anymore.
tia,
Ron.
It's hard to believe, for sure.
Have a merry New Year everyone. Hope you all have a profitable 2010.
Go Alda!!!
Ron.
Probably year end bonus buying.
Wish I got my bonus in Dec instead of Jan. Missed a lot of good buys over the years.
I'd consider that a "nice" problem to have.
I doubt that it affects the share price much tomorrow, but it's nice to know that they should report great sales increases for this period.
Just saw Terry and T36 on BC Global TV - short but sweet - product flying out the door
# 2 would be just fine. Hand sanitizers are becoming so popular that ALda probably even doesn't have to displace anyone. They just need to pick up a share of new business or sales when Purell is sold out.
They also have other products, don't forget.
Grainger has U.S. outlets. That could be one method for selling there.
Don't they need FDA approval before they can do anything in the U.S.?
Got my T36 Hand Sanitizer today.
Small bottles are nice.
Box is nice for shelf display.
Labels are slightly crooked.
Product feels good on the skin.
Ron.
cough, cough, cough.
Would be nice if they answered questions sent to their email address, too.
"Many will still play this short term as a penny stock...I'm looking to retire..... "
Same here :))
NEWS RELEASE PAGE
Headline: ALDA Grants Incentive Stock Options
Symbol: APH
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Oct. 16, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("ALDA") announces that it has granted incentive stock options to certain directors, senior officers, employees and consultants to purchase an aggregate of 750,000 common shares at an exercise price of $0.55 and a term of five years, expiring on October 15, 2014. The options and shares issuable upon exercise, if any, will be subject to a four-month hold period from the date of grant in accordance with TSX Venture Exchange policy. The grant was pursuant to the Company's Rolling Stock Option Plan, which was re-affirmed by the shareholders of the Company at an Annual General Meeting held on December 12, 2008 and subsequently accepted by the Exchange. The total number of options outstanding after this grant will be 5,620,000.
About ALDA Pharmaceuticals Corp. (www.aldacorp.com)
ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH and on the OTCBB under the symbol APCSF.
Terrance G. Owen, Ph.D., MBA, President & CEO
ALDA Pharmaceuticals Corp.
Retail Sales
London Drugs (http://www.londondrugs.com/Cultures/en-US/StoreLocator.htm)
Commercial Sales
Acklands-Grainger Inc. (www.acklandsgrainger.com)
Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as "outlook," "will," "could," "would," "might," "remains," "to be," "plans," "believes," "may," "expects," "intends," "anticipates," "estimate," "future," "plan," "positioned," "potential," "project," "remain," "scheduled," "set to," "subject to," "upcoming," and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
This is a start, but I'm waiting for quarterly results with real revenue and profits.
Keep APH up while I'm on vacation, guys.
Ron.
Time for a little dancing music, please.
TA hardly ever applies to a stock that is substantially under $1.
Ron.
Figures. I sold SSS yesterday @ .065
Ron.
I don't see any problem getting to $1.
APH News:
ALDA Pharmaceuticals Corp.
TSX VENTURE: APH
OTC Bulletin Board: APCSF
Other Recent News
May 6, 2009
ALDA Products Available Through Esthetics Plus Retailers
VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 6, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH)(OTCBB:APCSF) ("the Company" or "ALDA") advises that its products are available through the outlets served by the Company's exclusive distributors to the spa and salon markets, Eastern Esthetics and LCN Canada - West.
A list of retailers is provided at:
www.lcn.ca/SalonsRetailers/Canada/tabid/485/Default.aspx
A list of distributors is provided at:
www.lcn.ca/Distributors/LCNCanadianDistributors/tabid/480/Default.aspx
The products distributed by Esthetics Plus include:
- T36(R) Disinfectant
- T36(R) Antiseptic Hand Sanitizer Gel
- T36(R) Disinfectant Cleaner CONCENTRATE
About ALDA Pharmaceuticals Corp.
ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH and on the OTC BB under the symbol APCSF.
Terrance G. Owen, Ph.D., MBA, President & CEO
ALDA Pharmaceuticals Corp.
Cautionary Note Regarding Forward-looking Statements: Information in this press release that involves ALDA's expectations, plans, intentions or strategies regarding the future are forward-looking statements that are not facts and involve a number of risks and uncertainties. ALDA generally uses words such as "outlook", "will", "could", "would", "might", "remains", "to be", "plans", "believes", "may", "expects", "intends", "anticipates", "estimate", "future", "plan", "positioned", "potential", "project", "remain", "scheduled", "set to", "subject to", "upcoming", and similar expressions to help identify forward-looking statements. The forward-looking statements in this release are based upon information available to ALDA as of the date of this release, and ALDA assumes no obligation to update any such forward-looking statements. Forward-looking statements believed to be true when made may ultimately prove to be incorrect. These statements are not guarantees of the future performance of ALDA and are subject to risks, uncertainties and other factors, some of which are beyond its control and may cause actual results to differ materially from current expectations.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
CONTACT INFORMATION:
Retail Sales
Eastern Esthetics (ON, QU, NB, NS, PE, NL)
902-450-2161
or
Retail Sales
LCN Canada - West (MN, SN, AB, BC, NW, YK)
780-462-2580
or
ALDA Pharmaceuticals Corp.
Peter Chen
Distribution & Sales Contact
604-521-8300 Ext. 3
Fax: 604-521-8322
peter_chen@aldacorp.com
or
Distribution & Sales Contact
Scott Young
Investor Relations Contact
604-288-7222
syoung@freeformcom.com
www.aldacorp.com
INDUSTRY: Medical and Healthcare - Hospitals, Facilities and Providers, Medical and Healthcare - Healthcare, Medical and Healthcare - Surgery and Treatments, Pharmaceuticals and Biotech - Biotech, Pharmaceuticals and Biotech - Equipment and Supplies
You are receiving this email because you are subscribed to Marketwire's HOTW service using email address ron.hope@td.com If you want to un-subscribe from HOTW, please click here.
we're off and running
He's gnawing on a leg.
Especially nice to see bid at .31. Even my rsp shares are in profit.
Unfortunately, it will probably take a lot of lawsuits to get a product that actually works into our care facilities.
Ron.
Cheers!!
I think so, too.
Think I was wrong.
This could be really good (As good as Helix was?).
I would have to guess that it's not good news, based on today's trading. Hoping otherwise, of course.
Ron.
It's nice to be in the green again.
Big volume for little APH.
Got my extra shares today. Time to be in the .20's and stay there.
Ron.